Kymera Therapeutics, Inc.

NASDAQ:KYMR

42.2 (USD) • At close September 4, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q3
Operating Activities:
Net Income -76.614-65.581-70.752-62.487-42.062-48.557-14.368-52.867-38.799-40.928-34.865-43.002-40.257-36.684-33.9-28.582-24.66-13.075-12.685-7.987-13.989-10.932-11.513-11.42
Depreciation & Amortization 2.0842.0482.0251.9871.91.4610.8910.8950.90.8790.8180.7670.7050.6870.6890.6710.5520.4850.4970.490.3890.3870.3610.158
Deferred Income Tax 000000-17.8239.1548.669000000000000000
Stock Based Compensation 15.41614.23313.79914.90414.34111.96810.89811.65511.189.3858.9099.0769.6227.8738.6787.3965.7263.1721.8272.3280.6640.3710.2970.234
Change In Working Capital 1.351-27.325-3.551-0.971-13.132-6.31611.8939.887-7.12-11.978-13.493-1.052-9.732-13.346-15.455-18.423-13.361-14.684-11.278136.7261.413-1.994-0.057-1.556
Accounts Receivables -20-19.0530.370.3860.32715-14.9850.344-0.802-0.7830.346-0.513-1.10600.577000-0.57700000
Change In Inventory 00000014.985-0.3440.8020.783-0.34601.10601.6020000.58500000
Change In Accounts Payables -4.1333.917-0.5050.0920.0310.0751.5311.02-2.732.217-2.0684.168-0.41-1.437-1.028-2.923-0.1454.150.4670.895-0.211-0.1611.407-1.761
Other Working Capital 25.484-12.189-3.416-1.449-13.49-7.97910.3628.867-4.39-14.195-11.425-6.836-9.322-11.909-16.606-15.5-13.216-18.834-11.753135.8311.624-1.833-1.4640.205
Other Non Cash Items -2.121-2.525-3.305-3.62313.815.282-1.269-10.371-10.086-1.326-0.905-2.5590.6771.1751.6361.6781.2321.2791.5710.110.1110.1110.1110.11
Operating Cash Flow -59.884-79.15-61.784-50.19-42.936-39.5918.045-31.647-35.256-43.968-39.536-34.269-38.985-40.295-38.352-37.26-30.511-22.823-20.068131.667-11.412-12.057-10.801-12.474
Investing Activities:
Investments In Property Plant And Equipment -0.695-0.467-0.9360.189-4.689-7.402-11.625-8.078-10.768-4.009-0.373-1.246-0.735-0.482-0.501-0.306-0.626-0.164-1.437-2.409-3.855-1.395-0.199-0.211
Acquisitions Net 000000-30.577-68.589-46.607-1.3260.8890-82.5381.1755.807001.279000000
Purchases Of Investments -58.251-83.656-78.422-295.944-104.156-422.704-45.504-29.17-52.642-61.835-147.236-153.909-64.709-80.118-164.398-245.842-30.151-16.013-68.443-350.412-74.519-36.00862.158-78.112
Sales Maturities Of Investments 116.846130.213147.926127.359124.48799.49976.08197.75999.24990.42897.943117.674147.247106.46396.88109.28691.560.565.8918.531.5000
Other Investing Activites 2.1212.525010.71620.3313.07230.57768.58946.6071.326-0.889-36.23582.538-1.175-5.80700-1.279000000
Investing Cash Flow 60.02148.61568.568-157.6815.642-330.60718.95260.51135.83924.584-49.666-37.48181.80325.863-68.019-136.86260.72344.323-3.99-334.321-46.874-37.40361.959-78.323
Financing Activities:
Debt Repayment -0.382-0.277-0.293-0.641-0.352-0.290.925-0.34-0.334-0.327-0.305-0.292-0.269-0.264-0.156-0.352-0.186-0.155-0.152-0.109-0.151-0.142-0.118-0.085
Common Stock Issued 246.1080.5353.058246.5061.764350.1131.0090.1341.6391.486149.82500.6330-0.0290000.39800000
Common Stock Repurchased 000000000000000000000000
Dividends Paid 000000000000000000000000
Other Financing Activities 00599.6775.0531.7643.9331.00901.6391.4862.258150.7890.6330.4492.239246.3911.7780.750.024196.384-0.25293.26221.2110.044
Financing Cash Flow 245.7260.2582.765250.9181.412353.7561.934-0.2061.3051.1591.953150.4970.3640.1852.054246.0391.5920.5950.27196.275-0.40393.1221.093-0.041
Other Information:
Effect Of Forex Changes On Cash 0000000.001-18.2878.198000000000000000
Net Change In Cash 245.863-30.2779.54943.048-25.898-16.45628.93228.6581.888-18.225-87.24978.74743.182-14.247-104.31771.91731.80422.095-23.788-6.379-58.68943.6672.251-90.838
Cash At End Of Period 341.63695.773126.05116.50167.61293.51115.77786.84558.18756.29974.525161.77483.02739.84554.092158.40986.49254.68832.59356.38162.76121.44977.7895.538